World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
102
Citations
66042
World Ranking
656
National Ranking
383

Medicine

D-Index
104
Citations
66484
World Ranking
6895
National Ranking
3637

Overview

Robert T. Schooley is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with specific contributions to immunology and microbiology. The scientist's work spans several subfields including infectious diseases, virology, public health, environmental and occupational health, epidemiology, and parasitology.

Their research topics emphasize HIV/AIDS drug development and treatment, HIV research and treatment, and HIV/AIDS research and interventions. Additional areas of study include malaria research and control, HIV-related health complications and treatments, antibiotic resistance in bacteria, and antibiotics pharmacokinetics and efficacy.

Recent publications by Robert T. Schooley cover a range of topics pertinent to infectious diseases and HIV treatment. These include:

  • Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society-USA Panel, 2020, UNC Libraries
  • Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group, 2023, Clinical Infectious Diseases
  • Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial, 2022, Journal of the International AIDS Society
  • Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria, 2021, AIDS
  • Design and Implementation of Postgraduate Programs in Health in a Resource-Limited Setting in Mozambique (The Lúrio University), 2021, Advances in Medical Education and Practice

The scientist frequently collaborates with other researchers. Notable coauthors include Evelyn Hogg, John W. Mellors, Ann C. Collier, Emília Virgínia Noormahomed, and Constance A. Benson.

Robert T. Schooley has contributed to multiple publications in journals and venues such as UNC Libraries, Clinical Infectious Diseases, Journal of the International AIDS Society, AIDS, and Advances in Medical Education and Practice.

Best Publications

  • Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*

    Arthur J. Atkinson;Wayne A. Colburn;Victor G. DeGruttola;David L. DeMets

  • The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.

    Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Chronic Fatigue Syndrome: A Working Case Definition

    Gary P. Holmes;Jonathan E. Kaplan;Nelson M. Gantz;Anthony L. Komaroff

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell

  • Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome

    D D Ho;T R Rota;R T Schooley;J C Kaplan

  • Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

    Rebekah M. Dedrick;Carlos A. Guerrero-Bustamante;Rebecca A. Garlena;Daniel A. Russell

  • Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection

    Robert T. Schooley;Biswajit Biswas;Jason J. Gill;Adriana Hernandez-Morales

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis

    Richard J. Whitley;Charles A. Alford;Martin S. Hirsch;Robert T. Schooley

  • HIV-specific cytotoxic T lymphocytes in seropositive individuals.

    Bruce D. Walker;Sekhar Chakrabarti;Bernard Moss;Timothy J. Paradis

  • Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Reducing transmission of SARS-CoV-2.

    Kimberly A. Prather;Chia C. Wang;Robert T. Schooley

  • Ten scientific reasons in support of airborne transmission of SARS-CoV-2.

    Trisha Greenhalgh;Jose L Jimenez;Kimberly A Prather;Zeynep Tufekci

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Phage therapy: From biological mechanisms to future directions

    Unknown

  • Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • HIV infection is blocked in vitro by recombinant soluble CD4

    Richard A. Fisher;Jeanne M. Bertonis;Werner Meier;Victoria A. Johnson

  • HTLV-III in the semen and blood of a healthy homosexual man.

    David D. Ho;Robert T. Schooley;Teresa R. Rota;Joan C. Kaplan

  • Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.

    D D Ho;M G Sarngadharan;M S Hirsch;R T Schooley

Frequent Co-Authors

Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Constance A. Benson
Constance A. Benson University of California, San Diego
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Paul A. Volberding
Paul A. Volberding University of California, San Francisco
Margaret A. Fischl
Margaret A. Fischl University of Miami
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
Bruce D. Walker
Bruce D. Walker Harvard University
Scott M. Hammer
Scott M. Hammer Columbia University
Robert H. Rubin
Robert H. Rubin Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open diverse career opportunities. Nurse Practitioner programs, especially those focused on psychiatric and mental health nursing, often complement immunological studies by enhancing clinical skills and patient care knowledge. If you are considering such paths, exploring which nurse practitioner program is easiest can help you find a program that balances flexibility and depth while fitting your lifestyle.

Clinical placement is a critical factor in nursing education success. Choosing online pmhnp programs with clinical placement ensures hands-on experience, helping bridge theory and practice efficiently. Additionally, budget considerations come into play, making it essential to know about affordable pmhnp programs that maintain quality education without overwhelming financial burdens.

Ultimately, evaluating financial outcomes is important. Understanding how much a DNP makes by state can guide your decision-making process by providing insight into potential returns on investment after completing advanced nursing or immunology-related degrees.

Best Scientists Citing Robert T. Schooley

Trending Scientists